Skip to content

Feed Screener Search Methodology

SEC · FI · BAFIN · AFM · AMF

Pricing Sign in

InsiderLens

Statistics predict. AI explains.

Insider transactions from public regulatory disclosures, aggregated and enriched with deterministic statistical signals. Not investment advice.

Sources

SEC EDGAR · US
FINANSINSPEKTIONEN · SE
BAFIN · DE
AFM · NL
AMF · FR

Product

Methodology
Privacy notice
Object to processing

Feed Screener Search Methodology

Pricing Sign in

Dylan Tyler Michael — Cardium Therapeutics, Inc. insider: 2 transactions · InsiderLens

Home / Insiders / Dylan Tyler Michael

Dylan Tyler Michael

Director at Cardium Therapeutics, Inc. · on record since Nov 12, 2008
Secretary, General Counsel at Cardium Therapeutics, Inc. · on record since Oct 28, 2005

Insider trading activity of Dylan Tyler Michael

Transactions on record: 2; since Nov 12, 2008

Open-market buys: 0

Open-market sells: 0

Companies traded: 1; last filing Mar 4, 2014

Figures computed from official regulatory filings — methodology.

Companies where Dylan Tyler Michael has traded

Cardium Therapeutics, Inc.2 tx · Mar 4, 2014

Track record of Dylan Tyler Michael

Insufficient history for a statistical track record (fewer than 5 open-market buys).

Transaction history of Dylan Tyler Michael

Co-insiders of Dylan Tyler Michael

Adams DianeCardium Therapeutics, Inc.
Agrawal NeerajCardium Therapeutics, Inc.
Battery Investment Partners IX, LLCCardium Therapeutics, Inc.
Battery Investment Partners Select Fund I, L.P.Cardium Therapeutics, Inc.
Battery Management Corp.Cardium Therapeutics, Inc.
Battery Partners IX, LLCCardium Therapeutics, Inc.
Battery Partners Select Fund I GP, LLCCardium Therapeutics, Inc.

This page republishes public regulatory disclosures. Concerned by this data? Exercise your right to object →

Battery Partners Select Fund I, L.P.Cardium Therapeutics, Inc.

Battery Ventures IX, L.P.Cardium Therapeutics, Inc.

Battery Ventures Select Fund I, L.P.Cardium Therapeutics, Inc.

BROWN MICHAEL MAURICECardium Therapeutics, Inc.

CHAMBERS JOHN TCardium Therapeutics, Inc.

Coletta AnthonyCardium Therapeutics, Inc.

Conn Wilson GradCardium Therapeutics, Inc.

Corso JoyCardium Therapeutics, Inc.

Dominguez CarlosCardium Therapeutics, Inc.

Elhafed MoradCardium Therapeutics, Inc.

Feldman JesseCardium Therapeutics, Inc.

FLEISCHER RUSSELL LCardium Therapeutics, Inc.

Gabrielson Edward WCardium Therapeutics, Inc.

GILLIS EDWIN JCardium Therapeutics, Inc.

Gollamudi Raj L.Cardium Therapeutics, Inc.

Grainer James LCardium Therapeutics, Inc.

Griffith William J.G.Cardium Therapeutics, Inc.

Haley Daniel PCardium Therapeutics, Inc.

Harvey Scott MichaelCardium Therapeutics, Inc.

Hauser JanCardium Therapeutics, Inc.

Haverty KevinCardium Therapeutics, Inc.

Hellman & Friedman Capital Partners IX, L.P.Cardium Therapeutics, Inc.

Hellman & Friedman Investors IX, L.P.Cardium Therapeutics, Inc.

H&F Corporate Investors IX, Ltd.Cardium Therapeutics, Inc.

H&F Splash Holdings IX GP, LLCCardium Therapeutics, Inc.

H&F Splash Holdings IX, L.P.Cardium Therapeutics, Inc.

HUTCHISON MURRAY HCardium Therapeutics, Inc.

ICONIQ Strategic Partners-B, L.P.Cardium Therapeutics, Inc.

ICONIQ Strategic Partners GP, L.P.Cardium Therapeutics, Inc.

ICONIQ STRATEGIC PARTNERS II-B, L.P.Cardium Therapeutics, Inc.

ICONIQ Strategic Partners II GP, L.P.Cardium Therapeutics, Inc.

ICONIQ STRATEGIC PARTNERS II, L.P.Cardium Therapeutics, Inc.

ICONIQ Strategic Partners II TT GP, LtdCardium Therapeutics, Inc.

ICONIQ Strategic Partners, L.P.Cardium Therapeutics, Inc.

ICONIQ Strategic Partners TT GP, Ltd.Cardium Therapeutics, Inc.

Jacobson MatthewCardium Therapeutics, Inc.

Jemapete Christopher JCardium Therapeutics, Inc.

Kanouff Yvette MarieCardium Therapeutics, Inc.

KOSSUTH SELWYNCardium Therapeutics, Inc.

Kundra VivekCardium Therapeutics, Inc.

Lazzaron LucaCardium Therapeutics, Inc.

Lee Roger HCardium Therapeutics, Inc.

Leitch Andrew MCardium Therapeutics, Inc.

Company	Filed	Type	Qty	Price	Value · USD	Src
Cardium Therapeutics, Inc.	Mar 4, 2014	OtherD	448,550	—	—	SEC
Cardium Therapeutics, Inc.	Nov 12, 2008	OtherD	300,000	—	—	SEC